24Jul 2017

MEDICINE IMPORTATION PROCESS ASSESSMENT IN AFGHANISTAN DISSERTATION SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENT FOR THE AWARD OF THE DEGREE OF MASTER OF PUBLIC HEALTH.

  • MPH Student, Department of Public Health Maulana Azad University, Jodhpur.
Crossref Cited-by Linking logo
  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Background: For largely historical reasons of development in a post- or ongoing conflict situation, the current essential medicines importation mechanisms in Afghanistan are characterized by multiple funding sources and a large number of active players, giving rise to fragmented and, currently, largely uncoordinated service from multiple, vertical importation streams of varying efficiency.at present there is no formal platform to coordinate these activities. Method: The Medicine Importation Process Assessment was jointly carried out by the General Directorate of Pharmaceutical Affairs. The study is cross sectional study which questionnaires made and data collected from stakeholders through direct interview and email. The questionnaire made based on best practices in pharmaceutical importation system in Afghanistan. Result: Lack of coordination and absence of a coordination platform within the Ministry of Public Health is a big issues to be consider in the future , the importers didn?t hire technical staff to deal with documentation process technically, the importers submitting incomplete or non-original / fake documents for General Directorate of Pharmaceutical Affairs and Quality Control laboratory for analysis process, most of them bring incomplete information in the proforma ; the importers who import narcotic and controlled medicine didn?t submit consumption reports for narcotics and General Directorate of Pharmaceutical Affairs will not prove the next shipment documents till not receiving the consumption report . Some challenges are still exist in the processing of the importers documentation and some steps are redundant in the whole importation process like: Bureaucracy in General Directorate of Pharmaceutical Affairs, existence of Licensed Medicine List, short sampling, submitting incomplete or non-original documents to Quality Control laboratory by General Directorate of Pharmaceutical Affairs therefore most documents rejected by Quality Control laboratory, General Directorate of Pharmaceutical Affairs: poor storage conditions during sampling delivery to QC lab which there is no standards for chain of custody, time consuming in QC lab for analyzing of the medicine samples, in Drug Regulation Committee of ministry of counter narcotics time consuming this committee works parallel to MoPH, Tariff coding system and poor storage condition for the pharmaceuticals are a big challenge in the Afghanistan customs. The above mentioned challenges are need to consider and make a coordination body among all stakeholders and active players in Afghanistan. Conclusion The people and the pharmaceutical system harm from dis coordination, there is need for a formal platform to coordinate activities among several ministries.


  1. Functional Analysis of the General Directorate for Pharmaceutical Affairs of the Ministry of Public Health of Afghanistan
  2. Good Procurement Practice (GPP) and Good Distribution Practice (GDP), WHO.
  3. Managing Access to Medicines and Health Technologies MDS ? 3, MSH, distribution and procurement sections.
  4. Afghanistan medicine law
  5. Afghanistan Regulation on Manufacturing and Importing Medicine and Medical Appliances
  6. Afghanistan Medicine Quality Assurance Assessment
  7. Assessment Report of Quality Control Laboratory Ministry of Public Health Islamic Republic of Afghanistan Under Capacity Building & Access to Medicines Project (CBAM), 15/08/2010- 06/09/2010
  8. Quality assurance of pharmaceuticals, A compendium of guidelines and related materials, Volume 2, 2nd updated edition, World Health Organization 2007
  9. ASSESSMENT REPORT ON REGULATORY FRAMEWORK AND STRUCTURE FOR MEDICINES AND FOOD IN AFGHANISTAN November 2010
  10. National Licensed Medicines List of Afghanistan 2014
  11. Quality risk management (Q9); 2005.
  12. WHO Expert Committee on Specific cations for Pharmaceutical Preparations. Multisource (generic) pharmaceutical products: Guidelines on registration requirements to establish interchangeability (Annex 7 to TRS 937). Geneva: WHO; 2006.
  13. WHO Expert Committee on Specific cations for Pharmaceutical Preparations. National drug legislation: Guiding principles for small national drug regulatory authorities (Annex to TRS 790). Geneva: WHO; 1990.
  14. WHO Expert Committee on Specific cations for Pharmaceutical Preparations. Guiding principles for small national drug regulatory authorities (Annex to TRS790); 1990.
  15. WHO/DMP/RGS/98.2. How to introduce computer-assisted drug registration. Geneva: World Health Organization; 1998.
  16. WHO/DMP/RGS/98.3. A model system for computer-assisted drug registration: User Manual. Geneva: World Health Organization; 1998.
Winship K HD, Lawson DH,. The review of medicines in the UK. British Journal of Clinical Pharmacology.1992; 33(6):583-7.

[Sayed Murtaza Sadaat, Pharm D. (2017); MEDICINE IMPORTATION PROCESS ASSESSMENT IN AFGHANISTAN DISSERTATION SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENT FOR THE AWARD OF THE DEGREE OF MASTER OF PUBLIC HEALTH. Int. J. of Adv. Res. 5 (Jul). 1474-1485] (ISSN 2320-5407). www.journalijar.com


Sayed Murtaza Sadaat
N/A

DOI:


Article DOI: 10.21474/IJAR01/4860      
DOI URL: http://dx.doi.org/10.21474/IJAR01/4860